Skip to main content
. 2009 Dec 29;3:289–294. doi: 10.2147/dddt.s8133

Figure 1.

Figure 1

Efficacy of HBPG against HSV-2 encephalitis in mice after various delays in starting dosing post-infection. HBPG was given twice daily for five days.

Notes: For reduction of mortality, P < 0.05 at one and two days postinfection (Fisher’s exact test). For MDD, P < 0.05 at one and two days postinfection (Mann–Whitney U test).

Abbreviations: HBPG, 2-phenylamino-6-oxo-9-(4-hydroxybutyl)purine; HSV, herpes simplex virus; MDD, mean day of death.